Loading...

Omalizumab, an anti-immunoglobulin E antibody: state of the art

A large number of trials show that the anti-immunoglobulin (Ig) E antibody omalizumab is very effective in patients with severe allergic asthma. This is acknowledged in consensus documents. The drug also has a good safety profile and a pharmacoeconomic advantage due to a reduction in the number of h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Incorvaia, Cristoforo, Mauro, Marina, Russello, Marina, Formigoni, Chiara, Riario-Sforza, Gian Galeazzo, Ridolo, Erminia
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923619/
https://ncbi.nlm.nih.gov/pubmed/24532966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S49409
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!